Maryland Bids > Bid Detail

Turbo 293 Transfection Reagents

Back Print
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Level of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Opps ID: NBD00159151768180287
Posted Date: Jan 26, 2023
Due Date: Jan 26, 2023
Solicitation No: NOI-NIAID-2156472
Source: https://sam.gov/opp/4a28dbb38b...
Follow
Turbo 293 Transfection Reagents
Active
Contract Opportunity
Notice ID
NOI-NIAID-2156472
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NIAID
Looking for contract opportunity help?

Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.

General Information
  • Contract Opportunity Type: Presolicitation (Original)
  • All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Jan 26, 2023 09:23 am EST
  • Original Response Date: Jan 26, 2023 11:00 am EST
  • Inactive Policy: 15 days after response date
  • Original Inactive Date:
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325413 - In-Vitro Diagnostic Substance Manufacturing
  • Place of Performance:
    Bethesda , MD 20892
    USA
Description

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Speed Biosystems LLC for Turbo 293 transfection reagents.



The National Institute of Allergy and Infectious Diseases (NIAID)’s Vaccine Research Center (VRC) is developing vaccines for HIV-1, SARS-CoV-2, and other viruses. Production of various wild-type and mutant viral proteins and anti-viral antibodies is critical in vaccine development. To make these proteins in transient transfection protocol, transfection reagent is critical to the success of protein and antibody productions. In order to accomplish this, a specific type of transfection reagents called Turbo293 reagents are needed. Only this brand/type of reagents can be used due to technical and consistency requirements. See attached Justification document for more details.





The items required are as follows:




  • Quantity 20 each - Turbo293™ Transfection Reagent (20mL) [Part #PXX1002]






  • Shipping and Handling





Delivery shall occur within two (2) weeks of the date of award to Bethesda, Maryland 20892.





The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR QUOTE. All responsible sources that could provide comparable goods and/or services may submit a capability statement that will be considered by email subject line to reference NOI-NIAID-2156472 to Lu Chang at by 11:00 am eastern standard time 02/06/2023. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.




Attachments/Links
Contact Information
Contracting Office Address
  • 5601 FISHERS LANE, SUITE 3D11
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Jan 26, 2023 09:23 am ESTPresolicitation (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >